These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 33883498)

  • 21. Posterior Accumulation of Tau and Concordant Hypometabolism in an Early-Onset Alzheimer's Disease Patient with Presenilin-1 Mutation.
    Smith R; Wibom M; Olsson T; Hägerström D; Jögi J; Rabinovici GD; Hansson O
    J Alzheimers Dis; 2016; 51(2):339-43. PubMed ID: 26836192
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diverging longitudinal changes in astrocytosis and amyloid PET in autosomal dominant Alzheimer's disease.
    Rodriguez-Vieitez E; Saint-Aubert L; Carter SF; Almkvist O; Farid K; Schöll M; Chiotis K; Thordardottir S; Graff C; Wall A; Långström B; Nordberg A
    Brain; 2016 Mar; 139(Pt 3):922-36. PubMed ID: 26813969
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Carbon-11-Pittsburgh compound B positron emission tomography imaging of amyloid deposition in presenilin 1 mutation carriers.
    Knight WD; Okello AA; Ryan NS; Turkheimer FE; Rodríguez Martinez de Llano S; Edison P; Douglas J; Fox NC; Brooks DJ; Rossor MN
    Brain; 2011 Jan; 134(Pt 1):293-300. PubMed ID: 21084313
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Associations between biomarkers and age in the presenilin 1 E280A autosomal dominant Alzheimer disease kindred: a cross-sectional study.
    Fleisher AS; Chen K; Quiroz YT; Jakimovich LJ; Gutierrez Gomez M; Langois CM; Langbaum JB; Roontiva A; Thiyyagura P; Lee W; Ayutyanont N; Lopez L; Moreno S; Muñoz C; Tirado V; Acosta-Baena N; Fagan AM; Giraldo M; Garcia G; Huentelman MJ; Tariot PN; Lopera F; Reiman EM
    JAMA Neurol; 2015 Mar; 72(3):316-24. PubMed ID: 25580592
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tau Positron Emission Tomography in Autosomal Dominant Alzheimer Disease: Small Windows, Big Picture.
    McDade E; Bateman RJ
    JAMA Neurol; 2018 May; 75(5):536-538. PubMed ID: 29435570
    [No Abstract]   [Full Text] [Related]  

  • 26. Biological and Cognitive Markers of Presenilin1 E280A Autosomal Dominant Alzheimer's Disease: A Comprehensive Review of the Colombian Kindred.
    Fuller JT; Cronin-Golomb A; Gatchel JR; Norton DJ; Guzmán-Vélez E; Jacobs HIL; Hanseeuw B; Pardilla-Delgado E; Artola A; Baena A; Bocanegra Y; Kosik KS; Chen K; Tariot PN; Johnson K; Sperling RA; Reiman EM; Lopera F; Quiroz YT
    J Prev Alzheimers Dis; 2019; 6(2):112-120. PubMed ID: 30756118
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Presenilin-1 mutation is associated with a hippocampus defect in alzheimer's disease: Meta-Analysis for neuroimaging research.
    Gu X; Zhao M; Han X; Liu L
    Clin Neurol Neurosurg; 2020 Apr; 191():105679. PubMed ID: 32004985
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel PSEN1 p.Gly417Ala mutation in a Korean patient with early-onset Alzheimer's disease with parkinsonism.
    Giau VV; Wang MJ; Bagyinszky E; Youn YC; An SSA; Kim S
    Neurobiol Aging; 2018 Dec; 72():188.e13-188.e17. PubMed ID: 30180983
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel mutation (G217D) in the Presenilin 1 gene ( PSEN1) in a Japanese family: presenile dementia and parkinsonism are associated with cotton wool plaques in the cortex and striatum.
    Takao M; Ghetti B; Hayakawa I; Ikeda E; Fukuuchi Y; Miravalle L; Piccardo P; Murrell JR; Glazier BS; Koto A
    Acta Neuropathol; 2002 Aug; 104(2):155-70. PubMed ID: 12111359
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Late-onset presentation and phenotypic heterogeneity of the rare R377W PSEN1 mutation.
    Scarioni M; Arighi A; Fenoglio C; Sorrentino F; Serpente M; Rotondo E; Mercurio M; Marotta G; Dijkstra AA; Pijnenburg YAL; Scarpini E; Galimberti D
    Eur J Neurol; 2020 Dec; 27(12):2630-2634. PubMed ID: 32894632
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Case of Early-Onset Alzheimer's Disease Mimicking Schizophrenia in a Patient with Presenilin 1 Mutation (S170P).
    Kim HR; Jang JH; Ham H; Choo SH; Park J; Kang SH; Hwangbo S; Jang H; Na DL; Seo SW; Baek JH; Kim HJ
    J Alzheimers Dis; 2021; 83(3):1025-1031. PubMed ID: 34366354
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association Between Longitudinal Plasma Neurofilament Light and Neurodegeneration in Patients With Alzheimer Disease.
    Mattsson N; Cullen NC; Andreasson U; Zetterberg H; Blennow K
    JAMA Neurol; 2019 Jul; 76(7):791-799. PubMed ID: 31009028
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cortical microstructural correlates of astrocytosis in autosomal-dominant Alzheimer disease.
    Vilaplana E; Rodriguez-Vieitez E; Ferreira D; Montal V; Almkvist O; Wall A; Lleó A; Westman E; Graff C; Fortea J; Nordberg A
    Neurology; 2020 May; 94(19):e2026-e2036. PubMed ID: 32291295
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MR, (18)F-FDG, and (18)F-AV45 PET correlate with AD PSEN1 original phenotype.
    Saint-Aubert L; Payoux P; Hannequin D; Barbeau EJ; Campion D; Delisle MB; Tafani M; Viallard G; Péran P; Puel M; Chollet F; Demonet JF; Pariente J
    Alzheimer Dis Assoc Disord; 2013; 27(1):91-4. PubMed ID: 22517194
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The novel PSEN1 M84V mutation associated to frontal dysexecutive syndrome, spastic paraparesis, and cerebellar atrophy in a dominant Alzheimer's disease family.
    Gallo M; Frangipane F; Cupidi C; De Bartolo M; Turone S; Ferrari C; Nacmias B; Grimaldi G; Laganà V; Colao R; Bernardi L; Anfossi M; Conidi ME; Vasso F; Curcio SAM; Mirabelli M; Smirne N; Torchia G; Muraca MG; Puccio G; Di Lorenzo R; Piccininni M; Tedde A; Maletta RG; Sorbi S; Bruni AC
    Neurobiol Aging; 2017 Aug; 56():213.e7-213.e12. PubMed ID: 28532646
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel PSEN1 (S230N) mutation causing early-onset Alzheimer's Disease associated with prosopagnosia, hoarding, and Parkinsonism.
    Ringman JM; Casado M; Van Berlo V; Pa J; Joseph-Mathurin N; Fagan AM; Benzinger T; Bateman RJ; Morris JC
    Neurosci Lett; 2017 Sep; 657():11-15. PubMed ID: 28764909
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Progressive cognitive impairment and familial spastic paraparesis due to PRESENILIN 1 mutation: anatomoclinical characterization.
    Altuna M; Larumbe R; Zelaya MV; Moreno S; García-Solaesa V; Mendioroz M; Ramos MA; Erro ME
    J Neurol; 2022 Sep; 269(9):4853-4862. PubMed ID: 35438347
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Associations of quantitative susceptibility mapping with Alzheimer's disease clinical and imaging markers.
    Cogswell PM; Wiste HJ; Senjem ML; Gunter JL; Weigand SD; Schwarz CG; Arani A; Therneau TM; Lowe VJ; Knopman DS; Botha H; Graff-Radford J; Jones DT; Kantarci K; Vemuri P; Boeve BF; Mielke MM; Petersen RC; Jack CR
    Neuroimage; 2021 Jan; 224():117433. PubMed ID: 33035667
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnostic Performance of RO948 F 18 Tau Positron Emission Tomography in the Differentiation of Alzheimer Disease From Other Neurodegenerative Disorders.
    Leuzy A; Smith R; Ossenkoppele R; Santillo A; Borroni E; Klein G; Ohlsson T; Jögi J; Palmqvist S; Mattsson-Carlgren N; Strandberg O; Stomrud E; Hansson O
    JAMA Neurol; 2020 Aug; 77(8):955-965. PubMed ID: 32391858
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Accuracy of Tau Positron Emission Tomography as a Prognostic Marker in Preclinical and Prodromal Alzheimer Disease: A Head-to-Head Comparison Against Amyloid Positron Emission Tomography and Magnetic Resonance Imaging.
    Ossenkoppele R; Smith R; Mattsson-Carlgren N; Groot C; Leuzy A; Strandberg O; Palmqvist S; Olsson T; Jögi J; Stormrud E; Cho H; Ryu YH; Choi JY; Boxer AL; Gorno-Tempini ML; Miller BL; Soleimani-Meigooni D; Iaccarino L; La Joie R; Baker S; Borroni E; Klein G; Pontecorvo MJ; Devous MD; Jagust WJ; Lyoo CH; Rabinovici GD; Hansson O
    JAMA Neurol; 2021 Aug; 78(8):961-971. PubMed ID: 34180956
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.